FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2339754032> ?p ?o ?g. }

• W2339754032 endingPage "1547" @default.
• W2339754032 startingPage "1540" @default.
• W2339754032 abstract "Background— The risk of further intracranial hemorrhage (ICH) and the benefit of stroke risk reduction with the use of oral anticoagulants for patients who have atrial fibrillation with a history of ICH remain unclear. We aimed to investigate the risks and benefits in patients who have atrial fibrillation with a previous ICH treated with warfarin or antiplatelet drugs in comparison with no antithrombotic therapies. Methods and Results— This study used the National Health Insurance Research Database in Taiwan. Among 307 640 patients who have atrial fibrillation with a CHA 2 DS 2 -VASc score ≧2, 12 917 patients with a history of ICH were identified and were assigned to 1 of 3 groups, that is, no treatment, antiplatelet therapy, and warfarin. Among patients with previous ICH, the rate of ICH and ischemic stroke in untreated patients was 4.2 and 5.8 per 100 person-years, respectively. The annual ICH and ischemic stroke rates in warfarin users were 5.9% and 3.4%, respectively. Among users of antiplatelet agents, the rates were 5.3% per year and 5.2% per year, respectively. The number needed to treat for preventing 1 ischemic stroke was lower than the number needed to harm for producing 1 ICH with warfarin use for patients with a CHA 2 DS 2 -VASc score ≧6 (37 versus 56). The number needed to treat was higher than the number needed to harm for patients with a CHA 2 DS 2 -VASc score <6 (63 versus 53). Conclusions— Warfarin use may be beneficial for patients who have atrial fibrillation with a previous ICH having a CHA 2 DS 2 -VASc score ≧6. Whether the use of non–vitamin K antagonist oral anticoagulants could lower the threshold for treatment deserves further study." @default.
• W2339754032 created "2016-06-24" @default.
• W2339754032 creator A5000180119 @default.
• W2339754032 creator A5039836090 @default.
• W2339754032 creator A5043582125 @default.
• W2339754032 creator A5050762918 @default.
• W2339754032 creator A5051760777 @default.
• W2339754032 creator A5055177523 @default.
• W2339754032 creator A5067364011 @default.
• W2339754032 creator A5070376025 @default.
• W2339754032 creator A5072308879 @default.
• W2339754032 creator A5083368276 @default.
• W2339754032 creator A5085970149 @default.
• W2339754032 creator A5088579117 @default.
• W2339754032 creator A5089374332 @default.
• W2339754032 date "2016-04-19" @default.
• W2339754032 modified "2023-10-18" @default.
• W2339754032 title "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage" @default.
• W2339754032 cites W1985993462 @default.
• W2339754032 cites W1988911499 @default.
• W2339754032 cites W1990060616 @default.
• W2339754032 cites W1995044128 @default.
• W2339754032 cites W1999468381 @default.
• W2339754032 cites W2001603488 @default.
• W2339754032 cites W2011936209 @default.
• W2339754032 cites W2018214796 @default.
• W2339754032 cites W2022880742 @default.
• W2339754032 cites W2023373412 @default.
• W2339754032 cites W2028175223 @default.
• W2339754032 cites W2029248664 @default.
• W2339754032 cites W2042265219 @default.
• W2339754032 cites W2046206328 @default.
• W2339754032 cites W2050306424 @default.
• W2339754032 cites W2063976695 @default.
• W2339754032 cites W2070400683 @default.
• W2339754032 cites W2085975373 @default.
• W2339754032 cites W2095060228 @default.
• W2339754032 cites W2096721022 @default.
• W2339754032 cites W2097870377 @default.
• W2339754032 cites W2102464096 @default.
• W2339754032 cites W2114112775 @default.
• W2339754032 cites W2114775432 @default.
• W2339754032 cites W2121394112 @default.
• W2339754032 cites W2126858523 @default.
• W2339754032 cites W2136489990 @default.
• W2339754032 cites W2143034000 @default.
• W2339754032 cites W2152623033 @default.
• W2339754032 cites W2162586165 @default.
• W2339754032 cites W2165242637 @default.
• W2339754032 cites W3030533492 @default.
• W2339754032 cites W4297900745 @default.
• W2339754032 cites W50472604 @default.
• W2339754032 cites W620992480 @default.
• W2339754032 doi "https://doi.org/10.1161/circulationaha.115.019794" @default.
• W2339754032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26969761" @default.
• W2339754032 hasPublicationYear "2016" @default.
• W2339754032 type Work @default.
• W2339754032 sameAs 2339754032 @default.
• W2339754032 citedByCount "95" @default.
• W2339754032 countsByYear W23397540322016 @default.
• W2339754032 countsByYear W23397540322017 @default.
• W2339754032 countsByYear W23397540322018 @default.
• W2339754032 countsByYear W23397540322019 @default.
• W2339754032 countsByYear W23397540322020 @default.
• W2339754032 countsByYear W23397540322021 @default.
• W2339754032 countsByYear W23397540322022 @default.
• W2339754032 countsByYear W23397540322023 @default.
• W2339754032 crossrefType "journal-article" @default.
• W2339754032 hasAuthorship W2339754032A5000180119 @default.
• W2339754032 hasAuthorship W2339754032A5039836090 @default.
• W2339754032 hasAuthorship W2339754032A5043582125 @default.
• W2339754032 hasAuthorship W2339754032A5050762918 @default.
• W2339754032 hasAuthorship W2339754032A5051760777 @default.
• W2339754032 hasAuthorship W2339754032A5055177523 @default.
• W2339754032 hasAuthorship W2339754032A5067364011 @default.
• W2339754032 hasAuthorship W2339754032A5070376025 @default.
• W2339754032 hasAuthorship W2339754032A5072308879 @default.
• W2339754032 hasAuthorship W2339754032A5083368276 @default.
• W2339754032 hasAuthorship W2339754032A5085970149 @default.
• W2339754032 hasAuthorship W2339754032A5088579117 @default.
• W2339754032 hasAuthorship W2339754032A5089374332 @default.
• W2339754032 hasBestOaLocation W23397540321 @default.
• W2339754032 hasConcept C126322002 @default.
• W2339754032 hasConcept C127413603 @default.
• W2339754032 hasConcept C164705383 @default.
• W2339754032 hasConcept C2776301958 @default.
• W2339754032 hasConcept C2777015399 @default.
• W2339754032 hasConcept C2779161974 @default.
• W2339754032 hasConcept C2780645631 @default.
• W2339754032 hasConcept C71924100 @default.
• W2339754032 hasConcept C78519656 @default.
• W2339754032 hasConceptScore W2339754032C126322002 @default.
• W2339754032 hasConceptScore W2339754032C127413603 @default.
• W2339754032 hasConceptScore W2339754032C164705383 @default.
• W2339754032 hasConceptScore W2339754032C2776301958 @default.
• W2339754032 hasConceptScore W2339754032C2777015399 @default.
• W2339754032 hasConceptScore W2339754032C2779161974 @default.
• W2339754032 hasConceptScore W2339754032C2780645631 @default.

• next